T1	Participants 1232 1336	Patients had to have histologically documented measurable breast cancer and a performance status of 0-1.
T2	Participants 1337 1406	Patients could not have had prior chemotherapy for metastatic disease
T3	Participants 1451 1491	Patients could not have visceral crisis.
